Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$48.76 - $77.67 $307,188 - $489,321
-6,300 Reduced 68.48%
2,900 $0
Q3 2022

Oct 25, 2022

BUY
$61.42 - $86.29 $515,928 - $724,836
8,400 Added 1050.0%
9,200 $7,000
Q2 2022

Aug 04, 2022

BUY
$55.54 - $72.65 $38,878 - $50,855
700 Added 700.0%
800 $1,000
Q1 2022

Apr 14, 2022

BUY
$24.28 - $56.64 $2,428 - $5,664
100 New
100 $0
Q3 2021

Oct 26, 2021

SELL
$24.23 - $28.59 $2,423 - $2,859
-100 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$19.51 - $27.64 $11,706 - $16,584
-600 Reduced 85.71%
100 $0
Q4 2020

Jan 21, 2021

BUY
$10.75 - $14.91 $7,525 - $10,437
700 New
700 $0
Q1 2018

May 11, 2018

SELL
$14.85 - $24.3 $135,135 - $221,130
-9,100 Closed
0 $0
Q4 2017

Jan 17, 2018

SELL
$17.4 - $23.4 $3,479 - $4,680
-200 Reduced 2.15%
9,100 $2,000
Q3 2017

Oct 17, 2017

BUY
$15.5 - $19.15 $144,150 - $178,095
9,300
9,300 $6,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.